Protherics Plc

Protherics PLC: Protherics PLC Rule 2.10 Announcement

Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 12 hours ago

CHESHIRE, UK (MARKET WIRE)

Protherics PLC: Protherics PLC - Total Voting Rights

Market Wire - Pharmaceuticals and Biotech (Free subscription) | 02/10/2008

CHESHIRE, UK (MARKET WIRE)

Protherics PLC: Protherics PLC - Blocklisting Interim Review

Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 09/09/2008

Cheshire, UK (MARKET WIRE)

Protherics PLC: Protherics PLC -Total Voting Rights

Market Wire (Free subscription) | 02/09/2008

CHESHIRE, UK (MARKET WIRE) Protherics PLC

Start Of Prolarix™ Phase 2 Study In Liver Cancer

Medical News Today (Free subscription) | 29/08/2008

Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, announces the initiation of a phase 2a proof-of-concept study of Prolarix™, a targeted prodrug chemotherapy being developed for the treatment of primary liver cancer (hepatocellular carcinoma or "HCC").

Protherics PLC: Protherics PLC announces Holding(s) in Company-2

Market Wire - Pharmaceuticals and Biotech (Free subscription) | 14/08/2008

CHESHIRE, UK (MARKET WIRE)

Protherics PLC - Rule 2.10 Announcement

The Earth Times Online Newspaper (Free subscription) | 14/08/2008

CHESHIRE, UK -- 08/14/08 -- Protherics PLC Rule 2.10 Announcement London, UK; Brentwood, TN, US; 14 August 2008 In accordance with Rule 2.10 of the City Code on Tak..

• Protherics PLC: Protherics PLC - Rule 2.10 Announcement - Market Wire - Pharmaceuticals and Biotech

Protherics PLC: Protherics - Stmnt re Share Price Movement

Market Wire - Pharmaceuticals and Biotech (Free subscription) | 13/08/2008

Cheshire, UK (MARKET WIRE)

Protherics PLC: Protherics Plc - Blocklisting Interim Review

Market Wire (Free subscription) | 08/08/2008

CHESHIRE, UK (MARKET WIRE)

Protherics PLC: Protherics - Doc re Resolutions Passed at AGM

Market Wire (Free subscription) | 25/07/2008

Cheshire, UK (MARKET WIRE)

Protherics PLC: Protherics PLC announces Annual Information Update

Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 25/07/2008

Cheshire, UK (MARKET WIRE)

Protherics PLC: Protherics PLC announces AGM Proxy Results

Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 22/07/2008

Cheshire, UK (MARKET WIRE)

Protherics Plc Interim Management Statement

Red Orbit (Free subscription) | 22/07/2008

Protherics PLC AGM and Interim Management Statement London, UK; Brentwood, TN, US; 22 July 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, today provides its Interim Management Statement for the period 31 March to 21 July 2008.

Protherics PLC: Protherics Plc Interim Management Statement

Market Wire (Free subscription) | 22/07/2008

Cheshire, UK (MARKET WIRE)

Protherics PLC: Protherics announces Director/PDMR Shareholding

Market Wire - Pharmaceuticals and Biotech (Free subscription) | 10/07/2008

CHESHIRE, UK (MARKET WIRE)